$PACS

Murray Jason Hulse sold $3.5M of PACS

Murray Jason Hulse (Co-Founder, CEO & Chairman) sold 83,308 shares of PACS Group, Inc. (PACS) at an average of $42.00 ($41.13–$42.66, $3.50M total) across 4 trades over 2026-10-01 to 2026-10-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Murray Jason Hulse
Published Oct 5, 2026, 10:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 10:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PACS
Bearish
medium confidence
Mentioned
$PACS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PACSBearishLow
01

Why it matters

The disclosed sale reduces the CEO's ownership, which may be interpreted as a negative signal by the market.

02

Market read

While the transaction is a primary filing, its modest size limits broader market relevance.

03

What to watch

Potential tax planning or diversification motives for the insider.

Relevance 5/10Novelty 4/10Timing: after-hours filing on Oct 5

Background

Form 4 filings are primary disclosures of insider transactions required by the SEC.

Company-level read

Ticker impact

$PACSBearishMedium confidence
Context

SEC Form 4 shows CEO Murray Hulse sold $3.5M of shares, reducing his stake to 54.5M shares.

Expected impact

likely modest downward pressure as the market prices the insider sell

Evidence & confidence

The sale is sizable for a micro‑cap but not large enough to trigger a sharp move; investors typically watch insider activity closely.

Market effects

Minimal impact on the broader biotech/healthcare sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale could be a routine liquidity move unrelated to company fundamentals.

Key entities

  • Murray Jason Hulse

    Co‑Founder, CEO & Chairman of PACS Group, Inc.

  • PACS Group, Inc.

    Biotech company listed on NASDAQ under ticker PACS.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OHIMedAI 8/10

OMEGA TO TRANSITION OPERATIONS OF 32 FACILITIES IN FLORIDA TO PACS GROUP

OMEGA HEALTHCARE INVESTORS INC (OHI) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 303 International Circle Suite 200 Hunt Valley, MD 21030 P : 410.427.1700 F : 410.427.8800 PRESS RELEASE – FOR IMMEDIATE RELEASE OMEGA TO TRANSITION OPERATIONS OF 32 FACILITIES IN FLORIDA TO PACS GROUP HUNT VALLEY, MARYLAND – October 5, 2026 – Omega Healthcare Invest

$PACSHighAI 8/10

Why is PACS stock rallying today?

PACS stock rose 3.3% premarket after announcing two growth initiatives: acquiring 32 Florida nursing facilities and closing 11 more from the Eduro Healthcare deal, expanding its network to 355 buildings. The company's stock has recovered from a 52-week low of $7.50, now trading at $43.52. PACS's low leverage and favorable Medicare reimbursements support its growth strategy.

$PACSMed

PACS Group stock rises on Florida expansion, Eduro closings

PACS Group (NYSE:PACS) shares rose 3.3% premarket after announcing plans to acquire 32 Florida skilled nursing facilities, adding 4,049 beds. The deal, expected to close Q4, expands PACS's southern footprint. Additionally, PACS completed closings on 11 more Eduro Healthcare facilities, bringing total Eduro closings to 31 of 34. The company now operates 355 facilities across 7 states. CEO Jason Murray highlighted Florida's growth potential.

$PACSHigh

PACS Group, Inc. Reports Second Quarter 2026 Results

PACS Group, Inc. (PACS) filed an SEC Form 8-K — Results of Operations and Financial Condition. PACS Group, Inc. Reports Second Quarter 2026 Results Conference Call and Webcast Scheduled for Tomorrow, August 5, 2026, at 11:30 am ET. SALT LAKE CITY, Utah, August 4, 2026 – PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of

$PACSMedAI 8/10

Shearwater Group Contract Extension Worth £25m Lifts AIM Shares 17.6%

Shearwater Group said it secured a five-year £25m contract extension with a UK telecoms client, covering packet monitoring and forensic services. £12.5m is to be recognised in 2025-26, but cash is expected after year end; net cash is forecast at £5.6m and pre-tax profit at £1.1m. Shares rose 17.6% to 43.5p. Polar Capital and Supreme also moved on results.